FourThought Financial’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$9K Buy
598
+100
+20% +$1.65K ﹤0.01% 1052
2022
Q2
$8K Hold
498
﹤0.01% 1058
2022
Q1
$10K Sell
498
-1,000
-67% -$20.8K ﹤0.01% 1033
2021
Q4
$38K Hold
1,498
﹤0.01% 749
2021
Q3
$40K Hold
1,498
0.01% 749
2021
Q2
$43K Hold
1,498
0.01% 749
2021
Q1
$39K Hold
1,498
0.01% 746
2020
Q4
$42K Buy
+1,498
New +$39.8K 0.01% 697

Other funds holding BMEZ

FourThought Financial's BMEZ Position: Q3 2022 in Review

FourThought Financial increased its BlackRock Health Sciences Trust II (BMEZ) stake by 20% in Q3 2022, buying an estimated $1.65K and bringing the position to 598 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

FourThought Financial first reported a position in BMEZ in Q4 2020 and has held it in 8 quarters since. The position peaked at $43K in Q2 2021. 75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

  • FourThought Financial held 598 shares of BlackRock Health Sciences Trust II worth $9K as of Q3 2022.
  • FourThought Financial bought 100 BlackRock Health Sciences Trust II shares in Q3 2022, an estimated $1.65K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1052 holding.
  • FourThought Financial first reported a position in BlackRock Health Sciences Trust II in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's BlackRock Health Sciences Trust II position peaked at $43K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.